ARGS.OQ

Chart for ARGS.OQ

About

Argos Therapeutics Inc is a United States-based biopharmaceutical company. The company focused on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis technology platform. Its Arcelis technology platform is a personalized immunotherapy... (more)

Overall

Beta: --
Market Cap (Mil.): 128.74
Shares Outstanding (Mil.): 19.65
Dividend: --
Yield (%): --

Financials

  ARGS.OQ Industry Sector
P/E (TTM): -- 35.80 36.21
EPS (TTM): -2.66 -- --
ROI: -- 18.99 18.26
ROE: -- 19.76 19.13
Search Stocks

BRIEF-Home Retail's Argos, eBay to extend Click & Collect partnership

* Home Retail's Argos and eBay move to next stage of Click & Collect partnership

03 Jul 2014

UPDATE 1-UK's Argos says "click & collect" demand vindicates strategy

* Outcome is 8th straight quarter of like-for-like growth

12 Jun 2014

Colombia's Argos eyes Latin American energy investments -CEO

BOGOTA, April 30 - Grupo Argos, a Colombian holding company, is looking to invest in the energy sector elsewhere in Latin America later this year, its chief executive officer said on Wednesday.

30 Apr 2014

Colombian cement maker Argos buys French Guiana company from Lafarge, Holcim

BOGOTA, April 9 - Colombia's largest cement maker, Argos, said on Wednesday it will pay 50 million euros for a French Guiana company owned in equal parts by Lafarge and Holcim, two days after those companies announced a merger.

09 Apr 2014

UPDATE 1-Argos owner nudges up profit expectations after sales surge

LONDON, March 13 - Britain's Home Retail Group said annual profit would be slightly above the top end of market forecasts after it delivered a much stronger-than-expected finish to the year at its Argos and Homebase businesses.

13 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks